Benitec Biopharma Inc. (BNTC) vs ClearPoint Neuro, Inc. (CLPT)

A side-by-side comparison of Benitec Biopharma Inc. and ClearPoint Neuro, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNTC vs CLPT

growth of $100 · dividends reinvested · last 10y
BNTC -97.4% (-30.5%/yr)CLPT +88.9% (+6.6%/yr)CLPT compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$3$189
BNTC CLPT

BNTC vs CLPT: by the numbers

  • •CLPT is the larger company ($345M vs $317M market cap).
  • •Both run net losses; BNTC's is the smaller (0.00% vs -81.76% net margin).

Metrics side by side

Valuation

MetricBNTCCLPT
P/S ratioN/A8.17
P/B ratio1.7932.06

Profitability

MetricBNTCCLPT
Gross margin0.00%62.61%
Operating margin0.00%-65.36%
Net margin0.00%-81.76%
ROE-25.73%-320.77%
ROIC-28.88%-40.51%

Growth (annualized)

MetricBNTCCLPT
Revenue CAGR (5Y)N/A23.57%
Total return CAGR (5Y)-31.08%-7.65%

Frequently asked

How have BNTC and CLPT total returns compared?
Over the past 10 years, BNTC delivered -30.49% and CLPT delivered 6.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.